ghk-cu tolerance desensitization antibody formation long-term use Peptide: Clinical Evidence & Injectable Protocols Tripeptides Ghk and GhkCu-modified silver
Description
BPC-157 has been thoroughly researched for its therapeutic potential in a variety of conditions, including musculoskeletal injuries, digestive disorders, neurological conditions, autoimmune diseases, and skin and soft tissue injuries
Yamada K, Iwasaki N, Sudo H
Mller T, Laar TV, Cornblath DR et al (2013) Peripheral neuropathy in parkinsons disease: levodopa exposure and implications for duodenal delivery
medRxiv , 2023.2004.2013.23288227 (2023)
See the myofascial page for more information
